1.
Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells
by Hsu, Hsien-Yeh
Cancer letters, 2018-09-28, Vol.432, p.112-120
2.
The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma
by Shi, Qi
Cancer letters, 2018-09-28, Vol.432, p.56-68
3.
Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer
by Zhang, Yun-Kai Yun-Kai
Cancer letters, 2018-10-28, Vol.442, p.104-112
4.
Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo
by Wen, Shijun
Cancer letters, 2018-01-28, Vol.413, p.35-45
5.
Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells
by Bashari, O
Cancer letters, 2017-11-01, Vol.408, p.164-173
6.
Combined inhibition of PI3Kδ and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia
by He, Ye
Cancer letters, 2018-04-28, Vol.420, p.49-59
7.
Gambogic acid enhances proteasome inhibitor-induced anticancer activity
by Huang, Hongbiao
Cancer letters, 2010, Vol.301 (2), p.221-228
8.
Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin–platinum(II) conjugates
by Lottner, Christian
Cancer letters, 2004, Vol.203 (2), p.171-180
9.
Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity
by Zhang, Guoying
Cancer letters, 2000, Vol.159 (2), p.169-173
10.
Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene
by Inoue, Akira
Cancer letters, 2000, Vol.157 (1), p.105-112
11.
Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines
by Toma, Salvatore
Cancer letters, 1994, Vol.82 (2), p.209-216
12.
Synergistic effect between doxorubicin and a low dose of all-trans-retinoic acid in MCF-7 breast cancer cell line
by Toma, Salvatore
Cancer letters, 1997, Vol.116 (1), p.103-110
13.
Different frequencies of Porphyromonas gingivalis infection in cancers of the upper digestive tract
by Yuan, Xiang
Cancer letters, 2017-09-28, Vol.404, p.1-7
14.
A Tantalum Oxide-based Core/Shell Nanoparticle for Triple-modality Image-guided Chemo-thermal Synergetic Therapy of Esophageal Carcinoma
by Jin, Yushen
Cancer letters, 2017, Vol.397, p.61-71
15.
Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer
by Dong, Dawen
Cancer letters, 2015, Vol.359 (2), p.178-186
16.
The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1–thymopentin fusion peptide and its binding to TLR2
by Li, Juan
Cancer letters, 2013, Vol.337 (2), p.237-247
17.
Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5′-DFUR cytotoxicity
by Tsuneyoshi, Kengo
Cancer letters, 2006, Vol.244 (2), p.239-246
18.
Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism
by Ercoli, A
Cancer letters, 1996, Vol.108 (1), p.7-14
19.
Synergistic induction of rat microsomal CYP1A1 and CYP1A2 by acetone in combination with pyridine
by Iba, Michael M
Cancer letters, 1993, Vol.74 (1), p.69-74
